Vanguard Group
PASG icon

Vanguard Group’s Passage Bio PASG Stock Holding History

Vanguard Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.49M Buy
126,645
+9,615
+8% +$83K ﹤0.01% 3653
2025
Q3 		$937K Buy
117,030
+15,002
+15% +$104K ﹤0.01% 3809
2025
Q2 		$816K Sell
102,028
-1,549
-1% -$11.3K ﹤0.01% 3800
2025
Q1 		$731K Hold
103,577
– – ﹤0.01% 3794
2024
Q4 		$1.17M Hold
103,577
– – ﹤0.01% 3708
2024
Q3 		$1.45M Hold
103,577
– – ﹤0.01% 3660
2024
Q2 		$1.65M Hold
103,577
– – ﹤0.01% 3622
2024
Q1 		$2.8M Buy
103,577
+2,633
+3% +$63.4K ﹤0.01% 3490
2023
Q4 		$2.04M Buy
100,944
+50
+0% +$690 ﹤0.01% 3594
2023
Q3 		$1.33M Hold
100,894
– – ﹤0.01% 3736
2023
Q2 		$1.9M Hold
100,894
– – ﹤0.01% 3673
2023
Q1 		$1.93M Hold
100,894
– – ﹤0.01% 3682
2022
Q4 		$2.78M Buy
100,894
+41
+0% +$1.03K ﹤0.01% 3543
2022
Q3 		$2.52M Buy
100,853
+8,677
+9% +$342K ﹤0.01% 3653
2022
Q2 		$4.35M Buy
92,176
+5,431
+6% +$254K ﹤0.01% 3445
2022
Q1 		$5.38M Sell
86,745
-9,009
-9% -$742K ﹤0.01% 3494
2021
Q4 		$12.2M Sell
95,754
-3,398
-3% -$555K ﹤0.01% 3115
2021
Q3 		$19.8M Buy
99,152
+5,945
+6% +$1.42M ﹤0.01% 2870
2021
Q2 		$24.7M Buy
93,207
+25,262
+37% +$7.82M ﹤0.01% 2742
2021
Q1 		$23.8M Buy
67,945
+18,605
+38% +$7.94M ﹤0.01% 2698
2020
Q4 		$25.2M Buy
49,340
+23,445
+91% +$9.39M ﹤0.01% 2525
2020
Q3 		$6.79M Sell
25,895
-442
-2% -$152K ﹤0.01% 2994
2020
Q2 		$14.4M Buy
26,337
+25,765
+4,504% +$11.6M ﹤0.01% 2586
2020
Q1 		$181K Buy
+572
New +$179K ﹤0.01% 3878

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's PASG Position: Q4 2025 in Review

Vanguard Group increased its Passage Bio (PASG) stake by 8.2% in Q4 2025, buying an estimated $83K and bringing the position to 126,645 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3653.

Vanguard Group first reported a position in PASG in Q1 2020 and has held it in 24 quarters since. The position peaked at $25.2M in Q4 2020. 30 funds tracked by Wall St. Rank hold PASG as of Q4 2025.

  • Vanguard Group held 126,645 shares of Passage Bio worth $1.49M as of Q4 2025.
  • Vanguard Group bought 9,615 Passage Bio shares in Q4 2025, an estimated $83K.
  • Passage Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3653 holding.
  • Vanguard Group first reported a position in Passage Bio in Q1 2020 and has held it in 24 quarters since.
  • Vanguard Group's Passage Bio position peaked at $25.2M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.